These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19349713)
1. Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo. Ryan JL; Jones RJ; Elmore SH; Kenney SC; Miller G; Schroeder JC; Gulley ML Intervirology; 2009; 52(1):8-16. PubMed ID: 19349713 [TBL] [Abstract][Full Text] [Related]
2. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Rooney C; Taylor N; Countryman J; Jenson H; Kolman J; Miller G Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9801-5. PubMed ID: 2849118 [TBL] [Abstract][Full Text] [Related]
3. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Kelly BG; Lok SS; Hasleton PS; Egan JJ; Stewart JP Am J Respir Crit Care Med; 2002 Aug; 166(4):510-3. PubMed ID: 12186829 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. Ryan JL; Fan H; Glaser SL; Schichman SA; Raab-Traub N; Gulley ML J Mol Diagn; 2004 Nov; 6(4):378-85. PubMed ID: 15507678 [TBL] [Abstract][Full Text] [Related]
7. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Grogan E; Jenson H; Countryman J; Heston L; Gradoville L; Miller G Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1332-6. PubMed ID: 3029778 [TBL] [Abstract][Full Text] [Related]
9. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647 [TBL] [Abstract][Full Text] [Related]
10. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895 [TBL] [Abstract][Full Text] [Related]
11. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells. Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577 [TBL] [Abstract][Full Text] [Related]
12. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. Shannon-Lowe C; Adland E; Bell AI; Delecluse HJ; Rickinson AB; Rowe M J Virol; 2009 Aug; 83(15):7749-60. PubMed ID: 19439479 [TBL] [Abstract][Full Text] [Related]
13. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice. Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865 [TBL] [Abstract][Full Text] [Related]
14. Human oropharyngeal lesions with a defective Epstein-Barr virus that disrupts viral latency. Gan YJ; Shirley P; Zeng Y; Sixbey JW J Infect Dis; 1993 Dec; 168(6):1349-55. PubMed ID: 8245519 [TBL] [Abstract][Full Text] [Related]
15. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866 [TBL] [Abstract][Full Text] [Related]
16. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645 [TBL] [Abstract][Full Text] [Related]
17. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1. Dyson OF; Pagano JS; Whitehurst CB J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765 [TBL] [Abstract][Full Text] [Related]
18. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE mBio; 2020 Oct; 11(5):. PubMed ID: 33109754 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants? Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV Clin Microbiol Infect; 2014 Nov; 20(11):O861-9. PubMed ID: 24666405 [TBL] [Abstract][Full Text] [Related]
20. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells. Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ J Virol; 2020 May; 94(10):. PubMed ID: 32102884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]